Quarterly Revenue up more than 300%
sequentially
Successfully signed definitive agreement to
acquire RaGE Systems
Acquisition strategy successfully expanding end
markets and diversifying offerings
Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs” or the “Company”),
a fabless semiconductor company developing disruptive
next-generation connectivity solutions for wired, wireless 5G,
military, defense, aerospace, and medical industries, today
announced its financial results for the fiscal second quarter ended
March 31, 2024.
“I am excited about March quarter’s execution on foundational
milestones including our entering into a definitive agreement for
the synergistic acquisition of RaGE Systems, which is expected to
be immediately accretive,” said Fabian Battaglia, CEO of Mobix
Labs. “Looking ahead, we have set the stage for Mobix Labs’
continued best-in-class innovative solutions to capture
opportunities in the wireless, connectivity and electromagnetic
filtering industries, which we expect will create a versatile
company that serves diverse end markets.”
“We were pleased with our revenue growth of over 300%
sequentially,” commented Keyvan Samini President and CFO of Mobix
Labs. “We are growing profitability and we expect to have access to
substantial liquidity through our up to $100 million equity line of
credit with B. Riley Principal Capital II, LLC to support our
ambitious growth through strategic acquisition and, in the longer
term, we are targeting to achieve a 60% gross margin and a 30%
operating margin on a non-GAAP basis.”
Financial Highlights for Fiscal Second Quarter
of 2024
- Revenue: Total revenue grew to $1.1 million in the
second quarter of 2024, a 302% increase from $0.29 million in the
first quarter of 2024.
- Loss from Operations: GAAP loss from operations for the
quarter was $8.56 million, compared to a loss of $17.27 million for
the first quarter of 2024. Non-GAAP loss from operations for the
quarter was $4.08 million compared to $4.21 million for the first
quarter of 2024.
Recent Business Highlights
- Entered into a definitive agreement to acquire RaGE Systems,
which is expected to close later this month, to accelerate
industry-leading tech portfolio in next-generation wireless
communications, expanding Mobix Labs’ markets and diversifying
product portfolio.
- Announced a global distribution agreement with Arrow
Electronics (“Arrow”), a global provider of technology products and
services specializing in electronic components, enterprise
computing and intelligent solutions. Under the agreement, Arrow
will initially focus on Mobix Labs’ Electromagnetic Interference
(EMI) Filtering products, leveraging the strength of Arrow’s
presence in the defense and aerospace markets.
- Launched the MBX3110 SP10T high-power radio frequency (RF)
switch. This CMOS-based single-pole/ten-throw (SP10T) switch is
engineered to meet the demanding requirements of the land mobile
radio (LMR) market, including critical communications for first
responders, firefighters, law enforcement, and military
personnel.
- Secured an equity line of credit with B. Riley Principal
Capital II, LLC which provides that upon the satisfaction of
certain conditions, Mobix Labs will have access to up to $100
million.
- Sole source supplying custom filtered connectors used by
Gulfstream Aerospace Corp. Gulfstream designs, develops,
manufactures, markets, services and supports the world’s most
technologically advanced business-jet aircraft.
- Began selling proprietary electromagnetic filtering products to
GE HealthCare and PerkinElmer for use in pharmaceutical diagnostics
and digital imaging solutions.
- Announced MMS Technical Sales, Inc. (“MMS”) as new manufacturer
representative for electromagnetic filtering products in the New
England and Upstate New York territories.
- Announced delivery of key military connectivity solutions,
including filtered connector parts in connection with the Tomahawk
Missile System.
- Awarded guidance system component contract in connection with
the Javelin Missile System.
- Awarded M-1 Abrams Tank Army contract for filtered
connectors.
- Appointed electronics industry veteran Michael J. “Mike” Long
to its board of directors.
Financial Outlook
Subject to the closing of the Rage acquisition, we expect net
revenues within a range of approximately $1.8-$2.2 million in the
fiscal third quarter of 2024 and a range of $2.6 - $3.2 million in
the fiscal fourth quarter of 2024.
Non-GAAP Measures
The Company's results are determined in accordance with U.S.
generally accepted accounting principles (GAAP). Certain
information presented reflects adjustments to GAAP measures that
are referred in this presentation as “non-GAAP measures.”
Management believes these non-GAAP measures provide a more
comparable analysis of the underlying operating performance of the
business.
These non-GAAP measures include the following: Non-GAAP loss
from operations and non-GAAP gross margin. Each of these metrics
reflects certain adjustments. Non-GAAP loss from operations
excludes depreciation, amortization, merger and acquisition-related
expenses, inventory write-offs and stock-based compensation
expenses. Non-GAAP gross margin excludes amortization of
acquisition-related intangible assets, inventory write-offs and
stock-based compensation expenses.
These non-GAAP measures provide the Company with an
understanding of the results from the primary operations of its
business. The Company uses these metrics because management
believes they provide more comparable measures to evaluate
period-over-period operating performance since they exclude special
items that are not indicative of the Company's core business or
operations. These measures may be useful to an investor in
evaluating the underlying operating performance of the Company's
business.
Because all companies do not use identical calculations, the
Company's presentation of these non-GAAP financial measures may not
be comparable to similarly titled measures used by other companies.
Reconciliations of non-GAAP financial measures to the most directly
comparable GAAP financial measures are provided in the tables
herein.
Conference Call Information
Event:
Mobix Labs, Inc. Second Quarter 2024
Earnings Call
Date:
Tuesday, May 14, 2024
Time:
2:00 p.m. Pacific Time / 5:00 p.m. Eastern
Time
Webcast:
investors.mobixlabs.com
Dial-in number:
(646) 307-1963 // (800) 715-9871 Pin
#: 6233081
Shortly after the completion of the conference call, an archived
version of the webcast will be available on the Company’s investor
relations website at investors.mobixlabs.com.
About Mobix Labs, Inc
Based in Irvine, California, Mobix Labs is a fabless
semiconductor company delivering mmWave 5G and C-Band wireless
solutions and delivering connectivity and filtering products for
next-generation communication systems supporting the aerospace,
military, and high-reliability markets. The Company’s
electromagnetic filtering products are used in military, aerospace,
and medical applications. These technologies are designed for large
and rapidly growing markets where there are increasing demands for
higher-performance communication and filtering systems that utilize
an expanding mix of both wireless and connectivity technologies.
More information on the company can be found by visiting
http://www.mobixlabs.com or by following us on X @MobixLabsInc and
LinkedIn.
Forward-looking Information
This press release and the related earnings call contain
“forward-looking statements” regarding the intent, beliefs or
current expectations of the Company for purposes of the federal
securities laws. These forward-looking statements include, but are
not limited to, statements regarding Mobix Labs, Inc. and Mobix
Labs, Inc.’s management team’s expectations, hopes, beliefs,
intentions or strategies regarding the future. The words
“anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”
“intends,” “may,” “might,” “plan,” “possible,” “potential,”
“predict,” “project,” “should,” “will,” “would,” “poised” and
similar expressions may identify forward-looking statements, but
the absence of these words does not mean that a statement is not
forward-looking. Forward-looking statements in this presentation
and discussion may include, for example, statements about (i) our
agreement to acquire RaGE Systems and the anticipated timing of
closing, as well as any projections or expectations related to its
financial performance or its benefit to us; (ii) our expectations
related to the amount of proceeds available to us pursuant to our
equity line of credit with B. Riley Principal Capital II, LLC;
(iii) our financial outlook; (iv) future market conditions and (v)
any future product enhancements or developments. These
forward-looking statements are based on information available as of
the date of this presentation and discussion, and current
expectations, forecasts and assumptions, and involve a number of
judgments, risks and uncertainties. Accordingly, forward-looking
statements should not be relied upon as representing our views as
of any subsequent date, and we undertake no obligations to update
forward-looking statements to reflect events or circumstances after
the date they were made, whether as a result of new information,
future events or otherwise, except as may be required under
applicable securities laws. In addition, these forward-looking
statements and the information in this press release and the
earnings call are qualified in their entirety by cautionary
statements and risk factor disclosures contained in the Company’s
Securities and Exchange Commission filings, including the Company’s
Registration Statement on Form S-1 filed on May 2, 2024. All
forward-looking statements in this press release are based on
information available to us on the date hereof, and we assume no
obligation to update such statements.
As a result of a number of known and unknown risks and
uncertainties, our actual results or performance may be materially
different from those expressed or implied by these forward-looking
statements. Some factors that could cause actual results to differ
include (i) the risk that the price of our securities may be
volatile due to a variety of factors, including changes in the
highly competitive industries in which we operate, variations in
performance across competitors, changes in laws, regulations,
technologies, the global supply chain, and macro-economic and
social environments affecting our business; (ii) the inability to
meet future capital requirements and risks related to our ability
to raise additional capital including potential dilution to our
stockholders; (iii) the risk that we are unable to successfully
commercialize our products and solutions, or experience significant
delays in doing so; (iv) the risk that we may not be able to
generate income from operations in the foreseeable future; (v) the
risks concerning our ability to continue as a going concern; (vi)
the risk that we experience difficulties in managing our growth and
expanding operations; (vii) the risk that we may not be able to
consummate planned strategic acquisitions, or fully realize
anticipated benefits from past or future acquisitions or
investments; (viii) the risk that litigation may be commenced
against us; (ix) the risk that our patent applications may not be
approved or may take longer than expected, and we may incur
substantial costs in enforcing and protecting our intellectual
property; (x) the risk of being an early stage company and that our
limited operating history may make it difficult to evaluate our
future prospects and the risks and challenges that we may
encounter; (xi) the risk that we cannot predict whether we will
maintain revenue growth; (xii) the risk that the markets for our
semiconductor products and solutions are highly competitive; (xiii)
the risk that we may not satisfy the conditions to utilize the
committed equity facility with B. Riley Principal Capital II, LLC;
(xiv) our inability to predict the actual gross proceeds we may
receive pursuant to the committed equity facility with B. Riley
Principal Capital II, LLC; (xv) the risk that future sales of our
Class A Common Stock may cause the market price of our Class A
Common Stock to drop significantly, even if our business is doing
well; (xvi) the inability to maintain our listing of securities on
Nasdaq; (xvii) the impact of health epidemics, such as the COVID-19
pandemic, on our business and industry and the actions we may take
in response thereto and to other geopolitical concerns; and (xviii)
inflation and unfavorable global economic conditions could
adversely affect our business.
Mobix Labs, Inc. Condensed Consolidated Statements of
Operations and Comprehensive Loss (unaudited, in thousands,
except share and per share amounts) Three months
ended March 31, Six months ended March 31,
2024
2023
2024
2023
Net revenue Product sales
$
1,145
$
32
$
1,430
$
711
Costs and expenses Cost of revenue
952
209
1,281
903
Research and development
1,397
2,633
2,959
6,050
Selling, general and administrative
7,358
9,029
23,021
14,823
Loss from operations
(8,562
)
(11,839
)
(25,831
)
(21,065
)
Interest expense
248
794
1,105
877
Change in fair value of earn-out liability
(5,174
)
-
(29,938
)
-
Change in fair value of PIPE make-whole liability
(3,336
)
-
(432
)
-
Change in fair value of private warrants
420
-
480
-
Change in fair value of SAFEs
-
508
10
558
Merger-related transaction costs expensed
-
-
4,009
-
Other non-operating losses, net
1,049
-
1,049
-
Loss before income taxes
(1,769
)
(13,141
)
(2,114
)
(22,500
)
Provision (benefit) for income taxes
(16
)
1
(1,296
)
32
Net loss and comprehensive loss
(1,753
)
(13,142
)
(818
)
(22,532
)
Deemed dividend
661
-
661
-
Net loss available to common stockholders
$
(2,414
)
$
(13,142
)
$
(1,479
)
$
(22,532
)
Net loss per common share: Basic
$
(0.09
)
$
(0.94
)
$
(0.06
)
$
(1.71
)
Diluted
$
(0.21
)
$
(0.94
)
$
(0.10
)
$
(1.71
)
Weighted-average common shares outstanding: Basic
28,045,995
14,025,304
24,259,035
13,189,879
Diluted
29,199,253
14,025,304
24,914,569
13,189,879
Mobix Labs, Inc. Reconciliation of GAAP Loss from
Operations to Non-GAAP Loss from Operations (unaudited, in
thousands) Three Months Ended Six Months
Ended March 31, March 31,
2024
2023
2024
2023
Computation of non-GAAP loss from operations: GAAP loss from
operations
$
(8,562
)
$
(11,839
)
$
(25,831
)
$
(21,065
)
Depreciation
117
112
230
225
Amortization of acquisition related intangible assets
399
210
636
421
Merger and acquisition-related expenses
2,398
11
2,515
44
Inventory write-off
125
-
125
-
Stock-based compensation expense
1,441
5,779
14,146
9,635
Non-GAAP loss from operations
$
(4,082
)
$
(5,727
)
$
(8,179
)
$
(10,740
)
Three Months Ended Six Months Ended
March 31, March 31,
2024
2023
2024
2023
GAAP gross profit: GAAP net revenue
$
1,145
$
32
$
1,430
$
711
GAAP cost of revenue
952
209
1,281
903
GAAP gross profit
$
193
$
(177
)
$
149
$
(192
)
GAAP gross margin %
16.9
%
-553.1
%
10.4
%
-27.0
%
Computation of non-GAAP gross profit: GAAP gross profit
$
193
$
(177
)
$
149
$
(192
)
Amortization of acquisition-related intangible assets
68
68
136
136
Inventory write-off
125
-
125
-
Stock-based compensation expense
-
11
-
22
Non-GAAP gross profit
$
386
$
(98
)
$
410
$
(34
)
Non-GAAP gross margin %
33.7
%
-306.3
%
28.7
%
-4.8
%
Mobix Labs, Inc. Condensed Consolidated Balance
Sheets (unaudited, in thousands)
March 31,
September 30,
2024
2023
ASSETS Current assets Cash
$
2,993
$
89
Accounts receivable, net
461
53
Inventory
361
319
Prepaid expenses and other current assets
633
369
Total current assets
4,448
830
Property and equipment, net
1,763
1,859
Intangible assets, net
11,151
5,287
Goodwill
10,759
5,217
Operating lease right-of-use assets
946
1,030
Deferred transaction costs
-
4,125
Other assets
430
400
Total assets
$
29,497
$
18,748
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK
AND STOCKHOLDERS' EQUITY (DEFICIT) Current
liabilities Accounts payable
$
6,693
$
8,995
Accrued expenses and other current liabilities
7,036
4,519
Deferred purchase consideration
803
-
Notes payable
400
1,286
Notes payable - related parties
2,763
3,793
Simple agreements for future equity
-
1,512
Operating lease liabilities, current
332
318
Total current liabilities
18,027
20,423
Earn-out liability
3,621
-
PIPE derivative liability
1,639
-
Deferred tax liability
176
86
Operating lease liabilities, noncurrent
1,109
1,280
Other noncurrent liabilities
772
-
Total liabilities
25,344
21,789
Commitments and contingencies
Redeemable
convertible preferred stock
-
2,300
Stockholders' equity (deficit) Common stock
-
-
Additional paid-in capital
89,394
78,421
Accumulated deficit
(85,241
)
(83,762
)
Total stockholders' equity (deficit)
4,153
(5,341
)
Total liabilities, redeemable convertible preferred stock and
stockholders' equity (deficit)
$
29,497
$
18,748
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240514670739/en/
Media Contact: Jeff Fox, The Blueshirt Group
jeff@blueshirtgroup.com
Investor Contact: Lori Barker, The Blueshirt Group
lori@blueshirtgroup.com
Mobix Labs (NASDAQ:MOBX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Mobix Labs (NASDAQ:MOBX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025